Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2020 Jan 7;8(2):125–133. doi: 10.1016/S2213-8587(19)30413-9

Table 3.

Hazard ratios for association between smoking cessation and all-cause and cause-specific mortality among individuals with diabetes after excluding those who died within 6 years after quitting*

Current smokers Long-term quitters according to weight gain within 6 years after quitting Never smoked
≤0 kg 0.1–5.0 kg >5.0 kg
All-cause mortality
Person-years 23,921 5,184 2,839 3,806 117,061
Cases 721 269 121 156 2,560
Crude incident rate per 1000 person-years 30.14 51.89 42.62 40.99 21.87
Multivariable adjusted 1.00 0.69 (0.58, 0.82) 0.57 (0.45, 0.71) 0.51 (0.42, 0.62) 0.40 (0.36, 0.44)
CVD mortality
Cases 242 98 45 45 874
Crude incident rate per 1000 person-years 10.11 18.90 15.85 11.82 7.47
Multivariable adjusted 1.00 0.84 (0.63, 1.12) 0.66 (0.46, 0.95) 0.47 (0.32, 0.67) 0.45 (0.38, 0.53)
Cancer mortality
Cases 205 58 24 36 507
Crude incident rate per 1000 person-years 8.57 11.19 8.45 9.46 4.33
Multivariable adjusted 1.00 0.71 (0.50, 0.99) 0.53 (0.33, 0.84) 0.55 (0.37, 0.83) 0.33 (0.27, 0.39)
*

There were no cases among transient quitters.

Adjusted for age (years), diabetes duration (years), sex (male, female), race (white, non-white), BMI shortly before diabetes diagnosis (<25.0, 25.0–29.9, 30.0–35.0, or >35.0 kg/m2), physical activity (in quintiles), alcohol intake (0, <5.0, 5.0–14.9, or ≥15.0 g/day), total energy (in quintiles), Alternative Healthy Eating Index score (in quintiles), family history of diabetes (yes, no), family history of myocardial infarction (yes, no), family history of cancer (yes, no), current aspirin use (yes, no), and current multivitamin use (yes, no), presence of hypertension (yes, no), presence of hypercholesterolemia (yes, no), and diabetes medication use (oral hypoglycemic medication, insulin, or other).